Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency

NCT00095732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Pancreatic Insufficiency

Interventions

DRUG: Liprotamase
DRUG: Placebo

Sponsor

Anthera Pharmaceuticals

Collaborators

[object Object]